The short version of anti-doping fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-06-11 and is reviewed periodically as new material appears.
Analytical identification and purity assessment often use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Liquid chromatography–tandem mass spectrometry is used to detect and quantify SR9009 in biological matrices, including urine and blood, for anti-doping or pharmacokinetic studies. Nuclear magnetic resonance spectroscopy can confirm molecular structure. Stability depends on form and storage: the solid is generally more stable than solutions, and repeated freeze–thaw cycles may degrade samples. Purity is typically reported as a percentage from a certificate of analysis.
Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.
Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Common supplier description |
| Solubility | Soluble in DMSO and ethanol | Low solubility in water |
| Typical storage | −20 °C, desiccated, dark | For research samples |
| Analytical method | LC-MS/MS | Used for detection and quantification |
| Regulatory status | Prohibited in sport | WADA metabolic modulator class |
Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.
Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.
In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.
Handling recommendations for SR9009 in a laboratory setting include storing the solid at low temperature, protected from light and moisture. The compound is often dissolved in dimethyl sulfoxide or ethanol for experiments. Solutions should be prepared with appropriate personal protective equipment and disposed of according to local rules. Stability data for long-term storage are limited, so stock solutions are typically kept cold and used within defined periods. Records of preparation date and concentration support reproducibility.
SR9009 is not approved as a medicine by major regulatory agencies. It is commonly sold as a research chemical, a category that may fall outside customary drug approval and quality rules. In sports, the World Anti-Doping Agency lists SR9009 as a prohibited substance. Athletes who use it can face sanctions if it is detected in a sample. Legal status varies by country, and importation may be restricted. Enforcement practices differ across borders.
Detection of SR9009 in biological samples usually employs liquid chromatography coupled with tandem mass spectrometry. This method can identify the parent compound and sometimes metabolites in urine or blood. Because exposure can be low and clearance may be rapid, sample timing and limits of detection matter. Laboratories validate assays for sensitivity and specificity. Results are interpreted alongside chain-of-custody and quality-control records. Urine is the common matrix for anti-doping analysis, while blood may be used in research settings.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
Analytical identification of SR9009 typically relies on liquid chromatography coupled with tandem mass spectrometry. In biological samples, researchers first separate the compound from matrix components using protein precipitation, liquid-liquid extraction, or solid-phase extraction. High-performance liquid chromatography with ultraviolet detection and nuclear magnetic resonance spectroscopy can support structural confirmation of reference materials. Because SR9009 is a small, relatively lipophilic molecule, reverse-phase columns and acidic mobile phases are common. Laboratories often include isotope-labeled internal standards to improve quantification and to correct for ion suppression.
5-Fluorowillardiine – a synthetic modification of willardiine AMPATooltip α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid – a synthetic agonist after which the receptor is named Domoic acid – a naturally occurring agonist that causes amnesic shellfish poisoning Glutamic acid (glutamate) – the endogenous agonist Ibotenic acid – a naturally occurring agonist found in Amanita muscaria Quisqualic acid – a naturally occurring agonist found in certain species Willardiine – a naturally occurring agonist
Intending to wrest back the initiative, sever UNITA's logistics lifelines to South West Africa and Zaire, and forestall any future insurgent offensives, FAPLA launched Operation Saluting October in mid-1987. The impetus for Saluting October likely originated with the Soviet military mission, which pressed the idea of a major conventional thrust to destroy UNITA's southeastern front as early as 1983. It had received a new commander that year, Lieutenant General Pyotr Gusev, former deputy commander of the Carpathian Military District. In light of the war's length, its cost, the rising death toll, and looming cuts in the Soviet military expenditure which would limit future efforts to support FAPLA's war effort, Gusev wanted a decisive multi-divisional offensive to crush UNITA once and for all. Operation Saluting October was a two-pronged offensive aimed at retaking three major settlements from UNITA, Cangamba, Cassamba, and Mavinga. The FAPLA command staff intended the attack on Cangamba and Cassamba as a feint, hoping to draw UNITA forces there and away from Mavinga. Once Mavinga was in government hands, FAPLA could expel the remaining insurgents from Moxico Province and pave the way for a final assault on Savimbi's headquarters at Jamba. Between 4 and 9 Soviet advisers were to be attached on the battalion level, albeit with strict orders not to participate in the fighting and withdraw from the front as necessary to avoid contact with UNITA. They were accompanied by a small number of Cuban advisers and East German technical personnel serving in a variety of support roles.
In the case of compressed air, or nitrox mixtures, the exhaled gas is not valuable enough to justify the expense of recycling, but helium-based mixtures are considerably more expensive, and as the depth increases, the amount of gas used (in terms of mass, or number of molecules) increases in direct proportion to the ambient pressure. As a result, gas cost is a significant factor in deep open circuit diving with helium-based mixtures for long periods. By using a return line for the exhaled gas, it can be recompressed and used again, almost indefinitely. It is necessary to remove carbon dioxide from the reclaimed gas, but this is relatively cheap and uncomplicated. It is generally removed by a scrubber, which is a filter packed with a chemical which reacts with and removes the carbon dioxide from the gas. The reclaimed gas is also filtered to remove odour and microorganisms, and oxygen is added to the required concentration. The gas is compressed for storage between uses. Recovery of the exhaled gas requires special equipment. Simply venting it to a return hose through a non-return valve will not work, as the hose must be maintained at exactly the ambient pressure at the depth of the helmet, otherwise the gas from the helmet will either free-flow out under pressure, or not flow out at all because of back pressure.
Sources: en.wikipedia.org
===== Australia ===== Epilim Crushable Tablets Sanofi Epilim Sugar Free Liquid Sanofi Epilim Syrup Sanofi Epilim Tablets Sanofi Sodium Valproate Sandoz Tablets Sanofi Valpro Tablets Alphapharm Valproate Winthrop Tablets Sanofi Valprease tablets Sigma
==== Omicron variant ==== During the emergence of the Omicron variant of COVID-19 in December 2021 and January 2022, Ford's government announced in December 2021 new restrictions on indoor settings. After growing calls for third or booster doses of COVID-19 vaccines, the government allowed all Ontarians over 18 years of age to receive a third dose on December 20, 2021. On January 3, 2022, Ford announced that Ontario would be moving into modified Step 2 on January 5, closing indoor dining, gyms, movie theatres and schools.
== Research Contributions == GeneDx researchers have contributed to peer-reviewed publications in major scientific and medical journals, generating critical data to expand access to genomic testing. In 2020, GeneDx researchers co-authored a study published in Nature analyzing data from 31,058 exome trios to identify 28 previously undescribed genes associated with developmental disorders, providing diagnoses for approximately 500 families. A 2021 study in JAMA, using data from GeneDx, found that exome sequencing identified pathogenic or likely pathogenic variants in 32.7% of pediatric patients with cerebral palsy, providing evidence to support genetic testing guidelines for the condition. In 2025, GeneDx collaborated with Seattle Children's and the University of Washington on the SeqFirst research program, which produced two landmark publications. The SeqFirst-Neo study, published in the American Journal of Human Genetics, found that applying broad exclusion criteria for rapid genome sequencing in NICUs increased the odds of a precise genetic diagnosis ninefold compared to conventional care, with 42% of diagnosed infants having been missed under standard protocols. A companion study published in The Journal of Pediatrics demonstrated that implementing rapid genome sequencing as a first-tier test in non-critical pediatric inpatient wards reduced the average time to a precise genetic diagnosis from 289 days to 13 days.
Cloning – Dolly the sheep was the first mammal ever cloned from adult animal cells. The cloned sheep was, of course, genetically identical to the original adult sheep. This clone was created by taking cells from the udder of a six-year-old ewe and growing them in the lab. Gene therapy – a modified or healthy gene is inserted into the organism to replace a disease-causing gene. Commonly a virus that has been altered to carry human DNA is used to deliver the healthy gene to the targeted cells of the patient. This process was first used successfully in 1990 on a four-year-old patient who lacked an immune system due to a rare genetic disease called severe combined immunodeficiency (SCID).
Sources: en.wikipedia.org
==== Mechanism of action ==== Propranolol is a non-selective beta receptor antagonist. This means that it does not have preference to β1 or β2 receptors. It competes with sympathomimetic neurotransmitters for binding to receptors, which inhibits sympathetic stimulation of the heart. Blockage of neurotransmitter binding to β1 receptors on cardiac myocytes inhibits activation of adenylate cyclase, which in turn inhibits cAMP synthesis leading to reduced Protein kinase A (PKA) activation. This results in less calcium influx to cardiac myocytes through voltage-gated L-type calcium channels, meaning there is a decreased sympathetic effect on cardiac cells, resulting in antihypertensive effects including reduced heart rate and lower arterial blood pressure. Blocking neurotransmitter activity at β2 receptors in vascular smooth muscle cells causes vasoconstriction, leading to hypertension.
== Further reading == Carruthers JD, Fagien S, Joseph JH, Humphrey SD, Biesman BS, Gallagher CJ, et al. (January 2020). "DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Results from Each of Two Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Studies (SAKURA 1 and SAKURA 2)". Plastic and Reconstructive Surgery. 145 (1): 45–58. doi:10.1097/PRS.0000000000006327. PMC 6940025. PMID 31609882. Solish N, Carruthers J, Kaufman J, Rubio RG, Gross TM, Gallagher CJ (December 2021). "Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A". Drugs. 81 (18): 2091–2101. doi:10.1007/s40265-021-01631-w. PMC 8648634. PMID 34787840.
At the moment that each or every one of them is caught, whatever the circumstances, this resolution will be executed, without giving rise to minutes that provide requests and relationships capable of compromising compliance with this order and the honor of Your Excellency. This punishment must be the basis of the stability of the new system and a lesson for the chiefs of Peru, who advance to a thousand excesses for the hope of impunity and is at the same time the proof of the usefulness and energy with which this Expedition fills the important objects what is it intended for." There were also signs of Peruvian-phobia on the part of the Argentines of the Junta when Manuel Belgrano exposed on July 6, 1816, in front of the deputies of the Congress of Tucumán in two meetings, a proposal to establish an almost nominal monarchy, discussing first about choosing a European prince and then a Peruvian sovereign from the descendants of the Incas to offer the throne, it was most likely projected that the title would correspond to Juan Bautista Túpac Amaru, the only known surviving brother of the Inca noble, Túpac Amaru II, although they also considered Dionisio Inca Yupanqui, a mestizo jurist and soldier who had been educated in Europe and who was the representative of Peru at the Cortes of Cádiz, or Juan Andrés Jiménez de León Manco Cápac, a mestizo cleric and soldier who earned his fame for opposing the excessive collection of tribute and that he participated as a military commander in the uprising of Juan José Castelli.
Quality Management Development of new strategies for performance appraisal of hospital, out-patient clinics and laboratories. Development of quality-based documentation, database and communication systems or technical and administrative tools at TBRI. Development of quality-based safety systems for patients, personnel and utilized tools at TBRI, and upgrading of human capacity. In 2025, the Institute has over 3,000 researchers, mainly in the areas of cancer and infectious diseases.
=== Legal status === An advisory committee of the U.S. Food and Drug Administration (FDA) voted against the approval of oliceridine in 2018, due to concerns that the benefit of the drug did not exceed the risk. The risks of oliceridine include prolongation of the QT interval on the ECG, and depression of the respiratory drive (which could cause a person to stop breathing). As a result of the committee's vote, the FDA declined to approve oliceridine, citing safety concerns. Oliceridine was approved for medical use in the United States in August 2020. The FDA granted approval of Olinvyk to Trevena Inc. The DEA issued an interim final rule on October 30, 2020, designating oliceridine as CSA Schedule II (DEA Code 9245).
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is sold as a research chemical, but sports and medicine regulations restrict it.
Detection commonly uses liquid chromatography–tandem mass spectrometry. This method can identify the compound in urine or blood at low concentrations.
Typical guidance is −20 °C, dry, and protected from light. Solutions should be aliquoted and limited freeze–thaw cycles should be used.
Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.